| Overall | FMT | Placebo | P value |
---|---|---|---|---|
N | 55 | 28 | 27 | Â |
Age (mean ± SD) | 40.3 ± 6.3 | 40.9 ± 7.4 | 39.7 ± 5.2 | 0.685 |
Weight (mean ± SD) | 60.1 ± 3.9 | 59.2 ± 3.8 | 61.0 ± 4.0 | 0.833 |
Height (mean ± SD) | 1.67 ± 0.07 | 1.69 ± 0.04 | 1.65 ± 3.98 | 0.734 |
BMI (mean ± SD) | 21.7 ± 2.0 | 20.8 ± 1.6 | 22.5 ± 2.4 | 0.906 |
Male (%) | 20(36.4) | 10(35.7) | 10(37.0) | 0.906 |
Continue use of SIBO medication (%) | 33(60.0) | 17(60.7) | 16(59.3) | 0.579 |
Former tried SIBO medication (%) | 42(76.4) | 23(82.1) | 19(70.4) | 0.382 |
Former tried FODMAP diet (%) | 26(47.3) | 12(42.9) | 14(51.9) | 0.652 |
Born by casarean section (%) | 7(12.7) | 3(10.7) | 4(14.8) | 1 |
PPI (%) | 9(16.4) | 3(10.7) | 6(22.2) | 0.974 |
Antacid (%) | 8(14.5) | 4(14.3) | 4(14.8) | 0.523 |
Bile acid inhibitor (%) | 5(9.1) | 4(14.3) | 1(3.7) | 1 |
Immunosuppressor (%) | 2(3.6) | 1(3.6) | 1(3.7) | 1 |